PBAC Meeting Nov: Daratumumab combination and Pomalidomide combination

A couple of weeks ago we sent out a special advocacy edition of the Muster to inform you of the latest submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) for the upcoming November PB...

Cytogenetic testing in myeloma: The MMprofiler™

Cytogenetics is the study of chromosomes within a cell. Most commonly done at diagnosis, cytogenetic testing identifies the genetic mutations which characterise a person’s myeloma. This information he...

Big Al’s Blog

Back Testing in South Australia Day 1 – 3 – Park Rating 4 stars We started our trip on the 26 November having left Patterson Lakes at 11.00 heading off for our first two-night stop over. The tri...

American Society of Hematology (ASH) Conference 2018

A team from Myeloma Australia visited San Diego USA in December 2018 as invited guests of the International Myeloma Foundation (IMF). This gave us the opportunity to attend the world’s largest haemato...

10 Years

Back in December 2007 I was browsing the job classifieds in the local paper and came across an ad for an administration officer for the Myeloma Foundation of Australia Inc. I started at the end of Jan...

BLOOD

A team from Myeloma Australia had the opportunity to attend ‘Blood2018’ (formerly HAA) the largest haematology conference in Australia in Brisbane at the end of October. With our team of ten Myeloma S...

PBS listing changes for Pomalidomide – through the eyes of a Myeloma Support Nurse:

Just over two weeks ago, we were delighted to hear at Myeloma Australia the changes to the pharmaceutical benefit scheme (PBS) listing for Pomalidomide (Pomalyst®). Whilst the notation was slight, the...

Sydney City2Surf Running Blog

Running blog “Let the training commence” “White rabbits” “pinch, punch first day of the month” also day one of my training for “Team Myeloma” City to Surf 2018! I have entered this event several times...

PBAC consumer comments open for denosumab

Myeloma Australia is committed to keeping the Australian myeloma community informed about any new treatment submissions to be considered by the Pharmaceutical Benefits Advisory Committee (PBAC). The P...

Fundraising update

There is much activity at this time in the fundraising space of Myeloma Australia. Our first major fundraising event for the year was our flagship Business of Winning Luncheon at the MCG. This was a g...